ArticleNucleic acids research2025
RNA denaturation underlies circular RNA separation.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Emerging strategies and innovations in circular RNA synthesis.Molecular therapy. Nucleic acids · 2026Review
- Circular RNA as a New Vaccine Platform: Considerations, Challenges, and Perspectives.Vaccines · 2026Review
- Local delivery of IL-15 and anti-PD-L1 nanobody by in vitro-transcribed circILNb elicits superior antitumor immunity in cold tumors.Cell reports. Medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
In vitro-synthesized circular RNAs (circRNAs) have emerged as a promising drug modality for RNA therapeutics due to their improved stability and reduced immunogenicity. However, effective analysis and purification of circRNAs pose critical challenges arising from the insufficient separation of circRNAs and linear RNA byproducts. In this study, we systematically evaluate the effectiveness of gel electrophoresis and high-performance liquid chromatography-size exclusion chromatography (HPLC-SEC) for separating circRNAs synthesized through ligase- or ribozyme-based strategies. While the synthesis strategy dictates the purification complexity, we demonstrate that both techniques rely on RNA denaturation to successfully separate circRNAs. Additionally, when using HPLC-SEC, we show that even a trace amount of magnesium ions in RNA samples can significantly compromise circRNA separation. Under optimized denaturing conditions, HPLC-SEC enables circRNA purification directly from crude enzymatic reactions, thereby streamlining the purification process. Our study provides mechanistic insights into circRNA separation, advancing the purity and scalability of circRNA-based therapeutics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.